Molnupiravir 200mg Capsules
Molaz(Molnupiravir) 200mg Capsules is an experiment antiviral drug. It is a prodrug of the synthetic nucleoside derivative N4 – hydroxycytidine and exerts its antiviral action of copying errors during viral RNA replication.It is well tolerated and has a potent antiviral efficacy.
- It was developed for the treatment of influenza.
- Molaz(Molnupiravir) 200mg Capsule reduces the replication of SARS-CoV-2 and prevents infectious virus with rapid speed.
- Ongoing trials of the medicine state that the medicine prevents the progression of COVID-19 and eliminates onward transmission of SARS-CoV-2.
- Talk to your doctor about all the pros and cons of Molaz(Molnupiravir) medicine.
- Inform your doctor about all your medical history and tablet that you already intake to avoid contradictions.
- Maintain hygiene and do not come in contact with infected persons.
- Do not skip/discontinue the dose for effective treatment.
- Maintain proper time period between two doses. Do not overlap the doses.
- Monitor your health periodically.
| 药名 | 莫诺匹拉韦, 莫那比拉韦, 莫努匹拉韦 |
| 厂家 | 印度（AZLSTA） |
| 成分 | Molnupiravir200mg |
| 说明 |
Molnupiravir (EIDD-2801, MK-4482) 是一种口服生物活性的核糖核苷类似物β-d-N4-hydroxycytidine (NHC; EIDD-1931)的前药，具有广谱的抗病毒活性 antiviral activity 对抗 SARS-CoV-2、MERS-CoV、SARS-CoV 和 COVID-19的病
COVID-19（新冠肺炎变异）抗病毒药
|
* 以上中文信息由印度阿努卡药房收集的MOLAZ Molnupiravir 200mg 40 Capsules（莫诺匹拉韦, 莫那比拉韦, 莫努匹拉韦）中文网络信息和软件翻译获得，阿努卡药房认为MOLAZ Molnupiravir 200mg 40 Capsules（莫诺匹拉韦, 莫那比拉韦, 莫努匹拉韦）中文产品介绍信息存在与MOLAZ Molnupiravir 200mg 40 Capsules（莫诺匹拉韦, 莫那比拉韦, 莫努匹拉韦）实际数据不一致的可能。阿努卡药房请用户把MOLAZ Molnupiravir 200mg 40 Capsules（莫诺匹拉韦, 莫那比拉韦, 莫努匹拉韦）页面数据作为参考。印度阿努卡药房建议用户在实际使用MOLAZ Molnupiravir 200mg 40 Capsules（莫诺匹拉韦, 莫那比拉韦, 莫努匹拉韦）数据或者信息时，以MOLAZ Molnupiravir 200mg 40 Capsules（莫诺匹拉韦, 莫那比拉韦, 莫努匹拉韦）制造商公开发布的MOLAZ Molnupiravir 200mg 40 Capsules（莫诺匹拉韦, 莫那比拉韦, 莫努匹拉韦）商品信息为参考。使用方法，以用户医生建议使用MOLAZ Molnupiravir 200mg 40 Capsules（莫诺匹拉韦, 莫那比拉韦, 莫努匹拉韦）决定为参考。用户任何关于MOLAZ Molnupiravir 200mg 40 Capsules（莫诺匹拉韦, 莫那比拉韦, 莫努匹拉韦）的建议，可以通知印度阿努卡药房，或通知阿努卡在线客服人员。谢谢
